The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Δημοσίευση

The effect of selective estrogen receptor modulator administration on the hypothalamic-pituitary-testicular axis in men with idiopathic oligozoospermia.

TitleThe effect of selective estrogen receptor modulator administration on the hypothalamic-pituitary-testicular axis in men with idiopathic oligozoospermia.
Publication TypeJournal Article
Year of Publication2009
AuthorsTsourdi, E., Kourtis A., Farmakiotis D., Katsikis I., Salmas M., & Panidis D.
JournalFertil Steril
Volume91
Issue4 Suppl
Pagination1427-30
Date Published2009 Apr
ISSN1556-5653
KeywordsAdult, Dose-Response Relationship, Drug, Follicle Stimulating Hormone, Humans, Hypothalamo-Hypophyseal System, Luteinizing Hormone, Male, Middle Aged, Oligospermia, Raloxifene, Selective Estrogen Receptor Modulators, Sperm Count, Sperm Motility, Tamoxifen, Testis, Testosterone, Toremifene
Abstract

This study evaluates, compares, and contrasts the effects of three selective estrogen receptor modulators (SERMs), namely, tamoxifen, toremifene, and raloxifene, on the hypothalamic-pituitary-testicular axis in 284 consecutive subfertile men with idiopathic oligozoospermia using three therapeutic protocols: [1] tamoxifen, 20 mg, once daily (n = 94); [2] toremifene, 60 mg, once daily (n = 99); and [3] raloxifene, 60 mg, once daily (n = 91). The antiestrogenic effects of SERMs at the hypothalamic level result in a statistically significant increase of gonadotropin levels, which is more marked for tamoxifen and toremifene compared with raloxifene.

DOI10.1016/j.fertnstert.2008.06.002
Alternate JournalFertil. Steril.
PubMed ID18692782

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.